AHZANTIVE

What is this medication? Verzenio is a prescription medication containing the active ingredient abemaciclib, which belongs to a class of drugs called CDK4/6 inhibitors. This medication works by targeting and blocking specific proteins that allow cancer cells to grow and divide rapidly. It is primarily used for adults with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer that is either at a high risk of returning after surgery or has already spread to other parts of the body. The medication can be used on its own or in combination with hormonal therapies such as aromatase inhibitors or fulvestrant. It is typically prescribed for patients who have already undergone certain treatments or for those whose cancer has progressed following endocrine therapy. By slowing the progression of the cancer, Verzenio aims to delay the growth of the disease and improve outcomes for patients living with these specific forms of breast cancer.